Loan Financing, New TV Commercial, Earnings Releases, and Financial Guidance - Research Reports on MetLife, Aflac, BNY Mellon, SunTrust and Mallinckrodt

NEW YORK, October 22, 2014 /PRNewswire/ --

Today, Analysts Review released its research reports regarding MetLife, Inc. (NYSE: MET), AFLAC Inc. (NYSE: AFL), The Bank of New York Mellon Corporation (NYSE: BK), SunTrust Banks, Inc. (NYSE: STI) and Mallinckrodt public limited company (NYSE: MNK). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/7362-100free.

--
MetLife, Inc. Research Reports
On October 15, 2014, MetLife, Inc. (MetLife) announced that it has provided a $150 million agricultural mortgage loan to the Amaggi Group. According to MetLife, the loan has a floating rate and a term of 12 years and the debt is secured by a qualified real estate mortgage on developed farmland in the state of Mato Grosso, Brazil. Robert Merck, Senior Managing Director and Global Head of Real Estate for MetLife said, "This agricultural loan in Brazil is consistent with our strategy to invest in mortgages secured by high quality real estate in major markets. The Amaggi Group is one of the premier agricultural companies in Brazil, and we look forward to working with them to help them grow their business." Metlife informed that in Brazil, the Company currently has an agricultural loan portfolio of approximately $700 million. The full research reports on MetLife are available to download free of charge at:

http://www.analystsreview.com/Oct-22-2014/MET/report.pdf

--
AFLAC Inc. Research Reports
On October 6, 2014, AFLAC Inc. (Aflac) announced the launch of its first original Spanish-language television commercial called "Heights."  According to the Company, Heights, which is completely designed for the Hispanic audience, will air nationally on major Spanish-language networks through late November 2014. As per the Company, the commercial focuses on two window-washers who are on a scaffold many stories above the ground. Aflac added that Heights reinforces the theme of "protecting your plans" as the two characters in the Commercial discuss what's most important to them - their families - and how Aflac can help if they are unexpectedly sick or hurt. Michael Zuna, Executive Vice President and Chief Marketing Officer at Aflac, said, "We continue to see an upward trend in the number of policyholders and interest in supplemental benefits from the Hispanic market. Aflac understands that the Hispanic audience has different needs, different priorities and a slightly different way of communicating. In our new campaign, we're speaking directly to this important market with messaging they can more easily relate to rather than just translating our English campaigns into their language." The full research reports on Aflac are available to download free of charge at:

http://www.analystsreview.com/Oct-22-2014/AFL/report.pdf

--
The Bank of New York Mellon Corporation Research Reports
On October 17, 2014, The Bank of New York Mellon Corporation (BNY Mellon) announced its Q3 2014 financial results. During the quarter, the Company reported total revenue of $4.6 billion, up 21.9% YoY, while Assets Under Management increased 7.4% YoY to $1.6 billion. Net income applicable to common shareholders stood at $1.07 billion, or $0.93 per diluted common share, versus $962 million, or $0.82 per diluted common share, in Q3 2013. "We grew Investment Management and Investment Services fees, controlled expenses and executed on our capital plan. During the quarter, we also repositioned the Markets Group, which will improve our operating margin and return on capital," said Gerald L. Hassell, Chairman and CEO of BNY Mellon. The full research reports on BNY Mellon are available to download free of charge at:

http://www.analystsreview.com/Oct-22-2014/BK/report.pdf

--
SunTrust Banks, Inc. Research Reports
On October 17, 2014, SunTrust Banks, Inc. (SunTrust) announced its Q3 2014 financial results. The Company reported total revenue of $2.0 billion, up 5.8% YoY. Net income available to common shareholders stood at $563 million or $1.06 per diluted share, compared to $179 million or $0.33 per diluted share in Q3 2013. In the quarter, Tier 1 capital ratio stood at 10.50% versus 10.97% in Q3 2013. William H. Rogers, Jr., Chairman and CEO of SunTrust said, "We delivered solid performance this quarter driven by increased client loan and deposit business, further efficiency improvements, and continued strong asset quality performance, which helped mitigate the impact of the continued challenging low rate environment. We are creating positive momentum and are intensely focused on executing our core strategies, fulfilling more of our clients' needs, and delivering a more profitable and valuable company for all of our stakeholders." The full research reports on SunTrust are available to download free of charge at:

http://www.analystsreview.com/Oct-22-2014/STI/report.pdf

--
Mallinckrodt public limited company Research Reports
On October 14, 2014, Mallinckrodt public limited company (Mallinckrodt) announced financial guidance for its fiscal year ending September 25, 2015. For FY 2015, the Company anticipates its net sales (excluding the impact of fluctuations in foreign currency exchange rate) to be in the range of $3.65 billion to $3.75 billion, while net sales of its Specialty Pharmaceutical segment is expected to be in the range of $2.87 billion to $2.92 billion. For the stated period, Mallinckrodt expects adjusted diluted EPS to be in the range of $6.70 to $7.20. The full research reports on Mallinckrodt are available to download free of charge at:

http://www.analystsreview.com/Oct-22-2014/MNK/report.pdf

--
About Analysts Review
We do things differently. Our goal is to provide the best content to our exclusive membership. We are constantly hiring researchers, writers, editors and analysts to add to our team and become better than yesterday. If being a part of a fast growing community with an edge in today's market sounds interesting to you, then sign-up today and experience the full benefits of membership.


===============
EDITOR'S NOTES:
===============

1. This is not company news. We are an independent source and our views do not reflect the companies mentioned.

2. Information in this release is produced on a best efforts basis by Rohit Tuli, a CFA charterholder. The content is then further fact checked and reviewed by an outsourced research provider. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below.

3. This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.

4. If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at pubco [at] http://www.analystsreview.com.

5. For any urgent concerns or inquiries, please contact us at compliance [at] http://www.analystsreview.com.

6. Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to research [at] http://www.analystsreview.com for consideration.

COMPLIANCE PROCEDURE
Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Analysts Review, represented by Rohit Tuli, CFA. An outsourced research services provider has only reviewed the information provided by Analysts Review in this article or report according to the procedures outlined by Analysts Review. Analysts Review is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.

NOT FINANCIAL ADVICE
Analysts Review makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.

NO WARRANTY OR LIABILITY ASSUMED
Analysts Review is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Analysts Review whatsoever for any direct, indirect or consequential loss arising from the use of this document. Analysts Review expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Analysts Review does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE Analysts Review